Double Bond Pharmaceutical International AB (publ)

NGM:DBP B Stock Report

Market Cap: kr63.1m

Double Bond Pharmaceutical International Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Igor Lokot

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure9yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure5.5yrs

Recent management updates

Recent updates


CEO

Igor Lokot (51 yo)

9yrs

Tenure

Mr. Igor Lokot, PhD, serves as the Chief Executive Officer of Double Bond Pharmaceutical International AB (Publ) and serves as its President. Mr. Lokot served as Head of Research at Oasmia Pharmaceutical A...


Board Members

NamePositionTenureCompensationOwnership
Igor Lokot
CEO, President & Director9yrsno datano data
Sergey Yanitsky
Director9yrsno datano data
Sanna Rejnlander
Chairman1.9yrsno datano data
Irina Zaitseva
Director1.9yrsno datano data

5.5yrs

Average Tenure

54yo

Average Age

Experienced Board: DBP B's board of directors are considered experienced (5.5 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.